Member of Farmavita.Net offer transfer of marketing authorisation for Ciprofloxacine. Readily available is Ciprofloxacine, tablets 250-500 mg, bulk supply, with EU CTD Dossier. Marketing authorisation is obtained in EU in Reference Member State.
Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.
|Pharma licensing||Out-licensing (offer)|